Skip to main content

Ho William's Form 4 filing

RAPT Therapeutics, Inc.RAPT · filed Sep 20, 2021

Accession no.
0001593968-21-002152
Filed
Sep 20, 2021
Trade date
Sep 17, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions. Open-market sales total $77.9K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ho WilliamCIK 0001400901Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 17, 2021Common StockSSaleDisposed−616$38.86−$23,937.7664,490Direct
Sep 17, 2021Common StockSSaleDisposed−302$38.86−$11,735.7264,188Direct
Sep 17, 2021Common StockSSaleDisposed−3$38.96−$116.8864,185Direct
Sep 17, 2021Common StockSSaleDisposed−33$38.88−$1,283.0464,152Direct
Sep 17, 2021Common StockSSaleDisposed−1,046$39.06−$40,856.7663,106Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)